Epstein-Barr virus infection, Hodgkin's disease, non-Hodgkin's lymphoma, and reactive follicular hyperplasia in Japanese children: Evaluation of paraffin-embedded specimens using polymerase chain reaction and immunohistochemistry
Corresponding Author
HISAYUKI HIRAIWA MD
Department of Pathology, Shizuoka Children's Hospital, Shizuoka
Department of Pathology, Shizuoka Children's Hospital, 860 Urushiyama, Shizuoka City, Shizuoka 420, Japan.Search for more papers by this authorMINORU HAMAZAKI
Department of Pathology, Shizuoka Children's Hospital, Shizuoka
Search for more papers by this authorHIROAKI MURATA
Department of Pathology, Shizuoka Children's Hospital, Shizuoka
Search for more papers by this authorKIYOSU TANIGUCHI
Department of Pathology, Shizuoka Children's Hospital, Shizuoka
Search for more papers by this authorMINORU SAKURAI
Department of Pediatrics, Mie University School of Medicine, Mie, Japan
Search for more papers by this authorCorresponding Author
HISAYUKI HIRAIWA MD
Department of Pathology, Shizuoka Children's Hospital, Shizuoka
Department of Pathology, Shizuoka Children's Hospital, 860 Urushiyama, Shizuoka City, Shizuoka 420, Japan.Search for more papers by this authorMINORU HAMAZAKI
Department of Pathology, Shizuoka Children's Hospital, Shizuoka
Search for more papers by this authorHIROAKI MURATA
Department of Pathology, Shizuoka Children's Hospital, Shizuoka
Search for more papers by this authorKIYOSU TANIGUCHI
Department of Pathology, Shizuoka Children's Hospital, Shizuoka
Search for more papers by this authorMINORU SAKURAI
Department of Pediatrics, Mie University School of Medicine, Mie, Japan
Search for more papers by this authorAbstract
Epstein-Barr virus (EBV) infections are common in Japanese children, with infections by EBV type 1. The relationships between EBV infection and lymphadenopathies in Hodgkin's disease (HD), non-Hodgkin's lymphomas (NHL), reactive follicular hyperplasia (RFH), and infectious mononucleosis (IM) in 37 Japanese children were evaluated. Formalin-fixed, paraffin-embedded lymph node specimens that were obtained at surgical resection or biopsy were evaluated for the presence of EBV DNA and the latent membrane protein-1 (LMP-1) using polymerase chain reaction (PCR) and immunohistochemical staining. The PCR detected EBV DNA in nine of 13 (69.2%) patients with RFH, including a case of IM, all three (100%) patients with HD, and one of 21 (4.8%) patients with NHL. All EBV-positive samples contained EBV type 1. Reed-Sternberg's cells in HD were immunohistochemically positive for LMP-1, whereas all cases of RFH and NHL were negative for LMP-1. Results suggest that EBV infection may be related to HD. Although no proof exists that EBV infection contributes to the transformation of cells, thus causing RFH or NHL, the present authors suggest that the EBV-positive cases in Japanese children demonstrate a relationship between the clinical and histopathological features of the lymphadenopathy and EBV-type 1 infection.
References
- 1 Epstein MA, Achong BG, Barr YM. Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet 1964; 1: 702–3.
- 2 zur Hausen H., Schulte-Holthausen H., Klein G. et al. EBV DNA in biopsies of Burkitt tumours and aplastic carcinomas of the nasopharynx. Nature 1970; 228: 1056–8.
- 3 Weiss LM, Strickler JG, Warnke RA, Purtilo DT, Sklar J.. Epstein-Barr viral DNA in tissues of Hodgkin's disease. Am. J. Pathol. 1987; 129: 86–91.
- 4 Weiss LM, Movahed LA, Warnke RA, Sklar J.. Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease, N. Engl. J. Med. 1989; 320: 502–6.
- 5 Hamilton-Dutoit SJ, Pallesen G., Franzmann MB et al. AIDS related lymphomas. Histopathology, immunophenotype and association with Epstein-Barr virus as demonstrated by in situ nucleic acid hybridization. Am. J. Pathol. 1991; 138: 149–63.
- 6 Jones JF, Shurin S., Abramowsky C. et al. T-cell lymphoma containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections. N. Engl. J. Med. 1988; 318: 733–41.
- 7 Oda K., Tamaru J., Takenouchi T. et al. Association of Epstein-Barr virus with gastric carcinoma with lymphoid stroma. Am. J. Pathol. 1993; 143: 1063–71.
- 8 Gutensohn N., Cole P.. Childhood social environment and Hodgkin's disease. N. Engl. J. Med. 1981; 304: 135–40.
- 9 Rickinson AB, Young L., Rowe M.. Influence of the Epstein-Barr virus nuclear antigen EBNA 2 on the growth phenotype of virus-transformed B cells. J. Virol. 1987; 61: 1310–17.
- 10 Rappaport H., Bernard CW, Butler JJ, Dorfman RF, Lukes RJ, Thomas LB. Report of the committee on histological criteria contributing to staging of Hodgkin's disease. Cancer Res. 1971; 31: 1864–5.
- 11 Goelz SE, Hamilton SR, Vogelstein B.. Purification of DNA from formaldehyde fixed and paraffin embedded human tissue. Biochem. Biophys. Res. Commun. 1985; 130: 118–26.
- 12 Kunimoto M., Tamura S., Tabata T., Yoshie O.. One-step typing of Epstein-Barr virus by polymerase chain reaction: Predominance of type 1 virus in Japan. J. Gen. Virol. 1992; 73: 455–61.
- 13 Hiraiwa H., Hamazaki M., Murata H.. Hodgkin's disease in childhood. Analysis of Epstein-Barr virus using polymerase chain reaction method and immunohistochemical study of formalin-fixed, paraffin-embedded tissue sections. J. Clin. Exp. Med. 1994; 171: 911–2 (in Jpn.).
- 14 Saiki RK, Scharf S., Faloona F. et al. Enzymatic amplification of β-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 1988; 239: 1350–4.
- 15 Dambaugh T., Hennessy K., Chamnankit L., Kieff E.. U2 region of Epstein-Barr virus DNA may encode Epstein-Barr nuclear antigen 2. Proc. Natl Acad. Sci. USA 1984; 81: 7632–6.
- 16 MacMahon B.. Epidemiology of Hodgkin's disease. Cancer Res. 1966; 26: 1189–200.
- 17 Armstrong AA, Alexander FE, Paes, Pinto R. et al. Association of Epstein-Barr virus with pediatric Hodgkin's disease. Am. J. Pathol. 1993; 142: 1683–8.
- 18 Pallesen G., Mamilton-Dutoit SJ, Rowe M., Young LS. Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease. Lancet 1991; 337: 320–2.
- 19 Brousset P., Rochaix P., Chittal S., Rubie H., Robert A.. Delsol G.. High incidence of Epstein-Barr virus detection in Hodgkin's disease and absence of detection in anaplastic large-cell lymphoma in children. Histopathology 1993; 23: 189–91.
- 20 Tokunaga M., Nagasato H., Oyamada S. et al.. Epstein-Barr virus in Hodgkin's disease: An analysis using EBER-1 in situ hybridization. Pathol. Clin. Med. 1992; 10: 1161–7 (in Jpn. with Engl. abstract).
- 21 Chan JKC, Yip TTC, Tsang WYW, Lau W., Wong CSC, Ma VWS. Detection of Epstein-Barr virus in Hodgkin's disease occurring in an Oriental population. Hum. Pathol. 1995; 26: 314–8.
- 22 Tsujimoto Y., Cossman J., Jaffe E., Croce CM. Involvement of the bcl-2 gene in human follicular lymphoma. Science 1985; 228: 1440–3.
- 23 Stetler-Stevenson M., Cruch-Stanton S., Crossman J.. Involvement of the bcl-2 gene in Hodgkin's disease. J. Natl Cancer Inst. 1990; 82: 855–8.
- 24 Shibata D., Hu E., Weiss LM, Brynes RK, Nathwani BN. Detection of specific t(14;18) chromosomal translocations in fixed tissues. Hum. Pathol. 1990; 21: 199–203.
- 25 Henderson S., Rowe M., Gregory C. et al. Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 1991; 65: 1107–15.
- 26 Lorenzen J., Hamsmann M., Pezzella F. et al. Expression of the bcl-2 oncogene product and chromosomal translocation t(14;18) in Hodgkin's disease. Hum. Pathol. 1992; 23: 1205–9.
- 27 Hammerschmidt W., Sugden B., Baichwal VR. The transforming domain alone of the latent membrane protein of Epstein-Barr virus is toxic to cells when expressed at high levels. J. Virol. 1989; 63: 2469–75.
- 28 Shibata D., Hansmann M., Weiss LM, Nathwani BN. Epstein-Barr virus infections and Hodgkin's disease: A study of fixed tissues using the polymerase chain reaction. Hum. Pathol. 1991; 22: 1262–7.
- 29 Yamashita K., Tokunaga M.. Pathological study of Epstein-Barr virus related lymphadenitis. Pathol. Clin. Med. 1992; 10: 1425–31 (in Jpn. with Engl. abstract).
- 30 Hamazaki M., Taniguchi K., Murata H.. Immunological study of reactive follicular hyperplasia of lymph node in childhood. Jpn. J. Clin. Pathol. 1992; 40: 423–8 (in Jpn. with Engl. abstract).
- 31 Pezzalla F., Tse AGD, Cordell JL, Pulford KAF, Gatter KC, Mason DY. Expression of the bcl-2 oncogene protein is not specific for the 14;18 chromosomal translocation. Am. J. Pathol. 1990; 137: 225–32.
- 32 Wang F., Tsang S., Kurilla MG, Cohen JI, Kieff E.. Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1. J. Virol. 1990; 64: 3407–16.
- 33 Miller CL, Longnecker R., Kieff E.. Epstein-Barr virus latent membrane protein 2A blocks calcium mobilization in B-lymphocytes. J. Virol. 1993; 67: 3087–94.
- 34 Murray RJ, Wang D., Young LS et al. Epstein-Barr virus-specific cytotoxic T-cell recognition of transfectants expressing the virus-coded latent membrane protein LMP. J. Virol. 1988; 62: 3747–55.
- 35 Kissane JM, Gephardt GN. Lymphadenopathy in childhood. Long-term follow-up in patients with nondiagnostic lymph node biopsies. Hum. Pathol. 1974; 5: 431–9.
- 36 Stein H., Mason DY, Gerdes J. et al. The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: Evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 1985; 66: 848–58.
- 37 Herbst H., Dallenbach F., Hummel M. et al. Epstein-Barr virus DNA and latent gene products in Ki-1 (CD30)-positive anaplastic large cell lymphomas. Blood 1991; 78: 2666–73.
- 38 Lopategui JR, Gaffey MJ, Chan JKC et al. Infrequent association of Epstein-Barr virus with CD30-positive anaplastic large cell lymphomas from American and Asian patients. Am. J. Surg. Pathol. 1995; 19: 42–9.
- 39 Takada K., Horinouchi K., Ono Y. et al. An Epstein-Barr virus-producer line Akata: Establishment of the cell line and analysis of viral DNA. Virus Genes 1991; 5: 147–56.
- 40 Sandvej K., Peh S., Andresen BS, Pallesen G.. Identification of potential hot spots in the carboxy-terminal part of the Epstein-Barr virus (EBV) BNLF-1 gene in both malignant and benign EBV-associated disease: High frequency of a 30-bp deletion in Malaysian and Danish peripheral T-cell lymphomas. Blood 1994; 84: 4053–60.